Top Markets
Coin of the day
PharmaBlock Sciences (Nanjing), Inc. PharmaBlock Sciences (Nanjing), Inc.

PharmaBlock Sciences (Nanjing), Inc.

300725
Rank in Stocks #7576
PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical... PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical products and specialized services, supporting the pharmaceutical industry across the full spectrum of its operations – from initial research and development phases to large-scale commercial production. The company's primary offerings encompass: A vast inventory of chemical building blocks, available for supply at every stage of drug creation, from early discovery through to advanced development and commercial manufacturing. The creation of diverse chemical libraries, derived from their building blocks, specifically designed to accelerate drug discovery processes. Contract development and manufacturing (CDMO) services for essential pharmaceutical components, including raw starting materials (RSMs), chemical intermediates, active pharmaceutical ingredients (APIs), and finished drug products, catering to both clinical development programs and market demands. Established in 2006, PharmaBlock Sciences maintains its corporate headquarters in Nanjing, People's Republic of China.
Share Price
$6.59
Market Cap
$1.54B
Change (1 day)
-2.84%
Change (1 year)
9.06%
Country
CN
Trade PharmaBlock Sciences (Nanjing), Inc. (300725)

Category

P/E ratio for PharmaBlock Sciences (Nanjing), Inc. (300725)
P/E ratio as of 2026 TTM: 0
According to PharmaBlock Sciences (Nanjing), Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for PharmaBlock Sciences (Nanjing), Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.